PAD 0106 (Bromocriptine 2.5 mg)

Pill imprint PAD 0106 has been identified as Bromocriptine mesylate 2.5 mg.

Bromocriptine is used in the treatment of hyperprolactinemia; diabetes, type 2; acromegaly; tardive dyskinesia; parkinson's disease and belongs to the drug classes dopaminergic antiparkinsonism agents, prolactin inhibitors. There is no proven risk in humans during pregnancy. Bromocriptine 2.5 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for PAD 0106 (Bromocriptine 2.5 mg)

Bromocriptine mesylate 2.5 mg PAD 0106
Bromocriptine mesylate
Imprint:
PAD 0106
Strength:
2.5 mg
Color:
White
Size:
8.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Prolactin inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Paddock Laboratories, Inc.
National Drug Code (NDC):
00574-0106
Inactive Ingredients:
lactose anhydrous
silicon dioxide
magnesium stearate
maleic acid
povidone

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Advanced Breast Cancer: Learn about treatments to improve quality of life. Click Here

Close
Hide
(web5)